Immune checkpoint inhibitor therapy in HIV-associated Merkel cell carcinoma: A case series of 3 patients is a research paper published in JAAD Case Reports (2020). On theSindex it has a DataRank of 0.241. It has been cited 4 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.241
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Cancer Institute
Grant: P30-CA015704
National Institutes of Health
Grant: 1P01CA-225517
National Institutes of Health
Grant: K24-CA139052
NCI NIH HHS
Grant: K24 CA139052
NCI NIH HHS
Grant: P01 CA225517
NCI NIH HHS
Grant: P30 CA015704
National Institutes of Health
Grant: 5K24CA139052-07
Pathogenetic and prognostic studies for improved therapy of Merkel cell carcinoma
National Institutes of Health
Grant: 3P30CA015704-42S2
Cancer Center Support Grant
National Institutes of Health
Grant: 5P01CA225517-02
Immunobiology and Immune Therapy for Merkel Cell Carcinoma
Prostate Cancer Foundation
National Cancer Institute
National Institutes of Health
FWCI
0.23
Citation Percentile
0.5%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals